Enspryng

Drug Details

This medication is used to treat a certain nervous system disorder that affects the eye (optic) nerve and spinal cord (neuromyelitis optica spectrum disorder-NMOSD). Satralizumab belongs to a class of drugs known as monoclonal antibodies. It is not a cure for NMOSD but is thought to help by blocking interleukin-6, a substance made by the body. This effect may help to reduce the risk of attacks and delay or slow disability. It is also used to treat thyroid eye disease (TED). It may help improve symptoms of the disease, such as bulging eyes and double vision.